Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk for Cardiovascular Event”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06908473
What this trial is testing

Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients

Who this might be right for
Metabolic SyndromeCardiovascular Disease (CKD)Cerebrovascular Disease+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 530
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableStudy completedNCT01262222
What this trial is testing

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

Who this might be right for
High Risk for Postoperative Cardiovascular Events
Memorial Sloan Kettering Cancer Center 67
Testing effectiveness (Phase 2)Study completedNCT01652703
What this trial is testing

Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects

Who this might be right for
Hypercholesterolemia and High Risk for Cardiovascular Events
Amgen 310
Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190
Large-scale testing (Phase 3)Not Yet RecruitingNCT05175274
What this trial is testing

Colchicine Use for Primary Prevention of Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Qingdao Central Hospital 6,792
Not applicableUnknownNCT04087915
What this trial is testing

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)

Who this might be right for
DyslipidemiaHigh Risk Coronary Artery Disease
Beijing Anzhen Hospital 1,000
Post-approval studies (Phase 4)Study completedNCT00153101
What this trial is testing

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Who this might be right for
Cardiovascular Diseases
Boehringer Ingelheim 31,546
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Large-scale testing (Phase 3)Looking for participantsNCT07181109
What this trial is testing

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Who this might be right for
High Risk Cardiovascular DiseaseHypertensionHigh Cardiovascular Risk
Alnylam Pharmaceuticals 11,000
Large-scale testing (Phase 3)Study completedNCT00979589
What this trial is testing

Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeTransient Ischemic Attack
Beijing Tiantan Hospital 5,100
Not applicableNot Yet RecruitingNCT07563998
What this trial is testing

Prehospital Point-of-Care Hs-Troponin I for Rule-Out of Acute Myocardial Infarction in Patients Without ST-Segment Elevation

Who this might be right for
Myocardial Infarction (MI)Acute Coronary Syndromes (ACS)
Central Denmark Region 500
Post-approval studies (Phase 4)UnknownNCT01013532
What this trial is testing

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Who this might be right for
Brain IschemiaIntracranial Hemorrhages
Asan Medical Center 1,600
Large-scale testing (Phase 3)Study completedNCT01764633
What this trial is testing

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk

Who this might be right for
Dyslipidemia
Amgen 27,564
Post-approval studies (Phase 4)Ended earlyNCT01959425
What this trial is testing

Oral Anticoagulation Therapy Pilot Study

Who this might be right for
Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. 80
Post-approval studies (Phase 4)Looking for participantsNCT03264352
What this trial is testing

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Adverse EventBlood Pressure+2 more
XueQing Yu 11,414
Not applicableUnknownNCT06029933
What this trial is testing

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

Who this might be right for
InfluenzaCommunity-acquired PneumoniaCardiovascular Events
Kaiser Permanente 960,000
Not applicableStudy completedNCT05645640
What this trial is testing

Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk

Who this might be right for
Cardiovascular DiseasesRisk ReductionPrimary Prevention
China National Center for Cardiovascular Diseases 4,533
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Load More Results